Filing Flows › Comparisons › PFE vs ABT
Pfizer vs Abbott Laboratories: PFE and ABT compared
Pfizer is the larger company: $16.6B of revenue in its latest quarter (Q3 2026) against $13.0B for Abbott Laboratories (Q3 2026). Abbott Laboratories is growing faster (+14% against -0.4% a year earlier). Pfizer is more profitable, with an operating margin of 20.4% against 10.4%.
Where the money goes: PFE and ABT
Pfizer (PFE) · Q3 2026
Pfizer, Q3 2026: revenue $16.6B (-0.4% year over year), operating margin 20.4%, net earnings $3.3B, operating cash flow $5.4B. The chart follows the revenue to costs, profit and cash.
Abbott Laboratories (ABT) · Q3 2026
Abbott Laboratories, Q3 2026: revenue $13.0B (+14% year over year), operating margin 10.4%, net earnings $920M, operating cash flow $1.7B. The chart follows the revenue to costs, profit and cash.
| Pfizer (PFE) | Abbott Laboratories (ABT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $16.6B | $13.0B |
| Revenue growth, Y/Y | -0.4% | +14% |
| Operating margin | 20.4% | 10.4% |
| Net earnings | $3.3B | $920M |
| Net margin | 19.6% | 7.1% |
| Operating cash flow | $5.4B | $1.7B |
| Free cash flow | $4.8B | $1.2B |
| Market value | $169.0B | $197.4B |
| P/E | 42.0× | 42.4× |
| Analysts’ mean target | $30.11 | $118.52 |
Questions
Which is bigger, Pfizer or Abbott Laboratories?
Pfizer is the larger company: $16.6B of revenue in its latest quarter (Q3 2026) against $13.0B for Abbott Laboratories (Q3 2026).
Is Pfizer or Abbott Laboratories growing faster?
Abbott Laboratories is growing faster (+14% against -0.4% a year earlier).
Which is more profitable, Pfizer or Abbott Laboratories?
Pfizer is more profitable, with an operating margin of 20.4% against 10.4%.
More: Pfizer earnings · how Pfizer makes money · Abbott Laboratories earnings · how Abbott Laboratories makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.